Languages
Pages
Legal
Explore all categories to find your favorite topic
IMMUNOTHERAPY Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease Christoph T Ellebrecht1 Vijay G Bhoj2 Arben Nace1 Eun Jung Choi1…
The Use of Chimeric Antigen Receptors For the Creation of Retroviral Colorectal Cancer TargetsAbstract Colorectal Cancer is an aggressive disease that claims the lives of
Slide 1The Early Chimeric Antigen Receptor (CAR) T-cell Experience From An Academic Perspective Jakub Svoboda, MD University of Pennsylvania Philadelphia, PA • Diagnosed
A novel chimeric MOMP antigen expressed in Escherichia coli, Arabidopsis thaliana, and Daucus carota as a potential Chlamydia trachomatis vaccine candidateA novel chimeric
8.01.66 Chimeric Antigen Receptor Therapy for Multiple MyelomaMEDICAL POLICY – 8.01.66 Chimeric Antigen Receptor Therapy for Multiple Myeloma BCBSA Ref. Policy: 8.01.66
_therapy for solid tumours: microenvironment Sander Nijhof Master Biomedical Sciences 30th of November, 2018 Supervised by prof. dr. J.J. Schuringa and prof. dr. E. Bremer
Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges Sara Toulouie1, Gary Johanning2, Yihui Shi,1* 1. California Northstate University,
A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cellsA biomimetic five-module chimeric antigen receptor (5MCAR)
Park_Thesis_FinalUsing Binary Activated T Cells Expressing Chimeric Antigen Receptors (BAT CARs) to Improve Brain Tumor Immunotherapy Citation Park, Hyebin. 2019. Using Binary
Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domainsAnti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen
Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & TranslationScholarlyCommons ScholarlyCommons 2017 Development Of Canine Chimeric Antigen
1030A Grand A Muffly MASCC ISOO 2019 CART tox talk templateChimeric Antigen Receptor (CAR) T Cell Therapy Toxicity Lori Muffly MD MS Stanford University Conflict of Interest
Comparison of a chimeric anti- carcinoembryonic antigen antibody conjugated with visible or near- infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude…
Maurice Alexander PharmD BCOP CPP Clinical Specialist Blood and Marrow Transplant UNC Bone Marrow Transplant and Cellular Therapy Program Exploiting the Immune System: Chimeric…
REVIEW Chimeric antigen receptor CAR-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV Dongfang Liu1,2, Shuo Tian1, Kai…
Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates Agne Taraseviciute123 Victor Tkachev123 Rafael Ponce4 Cameron J Turtle2 Jessica M Snyder5 H…
March 2018 Volume 9 Article 4921 Original research published: 20 March 2018 doi: 10.3389fimmu.2018.00492 Frontiers in Immunology www.frontiersin.org Edited by: Vijayakumar…
PROGRESS IN HEMATOLOGY Recent Progress in Gene Therapy Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies Marco L. Davila • Diana
Anabolic Therapies for Osteoporosis in Postmenopausal Women: Effectiveness and ValueCancers: Effectiveness and Value PW: 5108747582 WIFI: NILE Why are we here today? •
1620 FormanDirector, T Cell Therapeutics Research Laboratory Current Status of Chimeric Antigen Receptor (CAR) T Cell Therapy City of Hope Comprehensive Cancer CenterCity